Ss Innovations International, INC. 8-K Filing
Ticker: SSII · Form: 8-K · Filed: Dec 8, 2025 · CIK: 1676163
Sentiment: neutral
Filing Stats: 526 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-12-08 08:35:24
Filing Documents
- ea0268739-8k_ssinno.htm (8-K) — 26KB
- ea026873901ex99-1_ssinno.htm (EX-99.1) — 11KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001213900-25-118977.txt ( ) — 211KB
- ssii-20251208.xsd (EX-101.SCH) — 3KB
- ssii-20251208_lab.xml (EX-101.LAB) — 33KB
- ssii-20251208_pre.xml (EX-101.PRE) — 22KB
- ea0268739-8k_ssinno_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On December 8, 2025, the Company issued a press release announcing that the Company submitted a 510(k) premarket notification to the United States Food and Drug Administration (the "FDA") on December 5, 2025, for its SSi Mantra surgical robotic system for multiple specialty procedure types, including: general, urological, colorectal, gynecological, and cardiac surgery. In addition, the Company provided updates regarding its European Union CE marking certification process and the cumulative installed base of SSi Mantra systems. A copy of the press release is included as Exhibit 99.1 to this Current Report.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated D ecember 8, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 8, 2025 SS INNOVATIONS INTERNATIONAL, INC. By: /s/ Sudhir Srivastava Sudhir Srivastava, M.D. Chairman and Chief Executive Officer 2